Drug major Lupin said its US arm Gavis has received approval from the US health regulator to market Hydrocodone Bitartrate and Acetaminophen tablets, a pain relieving drug, in the American market.
Gavis Pharmaceuticals, a subsidiary of the company, has received final approval for its Hydrocodone Bitartrate and Acetaminophen tablets from the US Food and Drug Administration (USFDA), Lupin said in a statement.
Research: Doctors Prescribe More Analgesics to Women Than to Men Just for Being Female
A woman is more likely to be prescribed pain-relieving drugs regardless of pain, social class or age.
Advertisement
‘The drugs are indicated for relief from moderate to moderately severe pain.’
Tweet it Now
The company's product, which is indicated for relief from moderate to moderately severe pain, is a generic equivalent of Mikart Inc's Hydrocodone Bitartrate and Acetaminophen tablets.
As per IMS MAT sales data, Hydrocodone Bitartrate and Acetaminophen tablets had sales of USD 89.6 million in the US market.
Currently, Lupin has the fifth largest pipeline of abbreviated new drug application (ANDA) filings pending approval with the USFDA.
Cumulative filings of the company with the USFDA now stand at 339, with the company having received approvals for 198 products.
Lupin's shares were trading at Rs 1,425 apiece on the BSE, up 1.24% from their previous close.
Source: Medindia
Currently, Lupin has the fifth largest pipeline of abbreviated new drug application (ANDA) filings pending approval with the USFDA.
Cumulative filings of the company with the USFDA now stand at 339, with the company having received approvals for 198 products.
Lupin's shares were trading at Rs 1,425 apiece on the BSE, up 1.24% from their previous close.
Source: Medindia
Non Addictive and Safe Opioid Analgesics Reported in Animal Models
The discovery of non addictive and safe opioid analgesics without any respiratory side effects was reported in animal models.
Advertisement
 Indian Government Clears Foreign Direct Investment Proposals of Lupin, Alkem LabThe Foreign Investment Promotion Board, chaired by Economic Affairs Secretary Shaktikanta Das, in its meeting considered 14 FDI proposals for approval. | Advertisement
|
Lupin’s Methergine Tablets for Postpartum Hemorrhage Now Hits US Markets
The tablets are used for the prevention and management of postpartum hemorrhage (PPH), a condition characterized by excessive bleeding during labor.
Advertisement
Recommended Reading
Latest Drug News
The effectiveness of adding fludrocortisone to hydrocortisone vs hydrocortisone alone among patients with septic shock was analyzed using target trial emulation.
Safety and effectiveness of commonly used painkillers (analgesics) for short-term relief of low back pain remain uncertain.
India's First Urinary Incontinence Drug Fesobig may offer Affordable treatment for Overactive Bladder (OAB), a widely prevalent problem among Indian men and women.
Oral anticoagulant drugs, particularly Rivaroxaban presented superior efficacy and safety than warfarin in atrial fibrillation patients with chronic kidney disease.
Patients with hepatitis D virus-related chronic advanced liver disease are treated with an antiviral therapy.